About ProTom
ProTom International Holding Corporation ("ProTom") is a medical technology company focused on proton beam therapy for patients with cancer. ProTom assembles, tests, sells and distributes the Radiance 330 Proton Therapy System. Radiance 330 has FDA 510(k) clearance for commercial distribution in the United States.
Ad Statistics
Times Displayed: 22201
Times Visited: 440 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
We are steadfast in our mission to transform cancer treatment by expanding the accessibility of proton therapy and by developing proton tomography technology. Combined with the fast return on investment, the precision of pencil beam scanning and the power of integrated imaging, ProTom's Radiance 330 proton therapy system is the choice for proton therapy technology.
About GHGK
Guohong Guokang (Beijing) Health Technology Development Co., LTD ("GHGK") is a proton therapy technology platform company established by the Sino Hope Group especially for the distribution of ProTom's Radiance 330 Proton Therapy System.
The mission of GHGK is to bring the best proton therapy technology to cancer patients in China and surrounding Asian countries. GHGK will provide ProTom with full support to develop the market for the Radiance 330 Proton Therapy System in agreed regions.
SOURCE ProTom International
Back to HCB News
